Emergent Biosolutions EBS Product and services sales, net — Total revenues

Other product segments

Similar metrics at other companies

ARDXProduct sales, net — Total revenues

$93.37M+37.7%

BCRXProduct sales, net — Total revenues

$151.4M+5.3%

ESPRProduct sales, net — Total Revenues

$43.4M+24.3%

SHCProduct — Total net revenues

$38.44M+25.7%

CRMDProduct sales, net — Total Revenue

$121.92M+212%

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

Questions, answered.

What is Emergent Biosolutions's product and services sales, net — total revenues?

Emergent Biosolutions (EBS) reported product and services sales, net — total revenues of $149.7M in Q1 2026.

How has Emergent Biosolutions's product and services sales, net — total revenues changed year-over-year?

Emergent Biosolutions's product and services sales, net — total revenues decreased by 28.4% year-over-year, from $209.1M to $149.7M.

What is the long-term trend for Emergent Biosolutions's product and services sales, net — total revenues?

Over 2 years (2023 to 2025), Emergent Biosolutions's product and services sales, net — total revenues has grown at a -17.0% compound annual growth rate (CAGR), from $1.02B to $705.2M.

What does product and services sales, net — total revenues mean?

This metric represents the total net revenue generated specifically from the company's product and service offerings, excluding other revenue streams. It serves as a primary indicator of the commercial performance and market adoption of the firm's core portfolio. Monitoring this figure helps investors assess the underlying demand for the company's specialized health solutions and the effectiveness of its commercialization strategy.